Dr. Stephen Russell, MD

• Hematology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Polish School Of Medicine

  Medical School

• The Sodium Iodide Symporter (NIS) as an Imaging Reporter for Gene, Viral, and Cell-based Therapies, 2012-02-01

• Utility of repeating bone marrow biopsy for confirmation of complete response in multiple myeloma, 2020-10-02

• MeV-Stealth: A CD46-specific oncolytic measles virus resistant to neutralization by measles-immune human serum, 2021-02-03

• Oncolytic Vaccinia Virotherapy for Endometrial Cancer, 2014-01-14

• Monoclonal gammopathy-associated thrombotic microangiopathy, 2019-07-17

• Retargeted and Stealth Modified Oncolytic Measles Viruses for Systemic Cancer Therapy in Measles-Immune Patients., 2020-08-26

• Curative one-shot systemic virotherapy in murine myeloma, 2012-03-19

• Noninvasive Imaging and Radiovirotherapy of Prostate Cancer Using an Oncolytic Measles Virus Expressing the Sodium Iodide Symporter, 2009-09-22

• Natural history of multiple myeloma with de novo del(17p), 2019-03-07

• Curative ex vivo liver-directed gene therapy in a pig model of hereditary tyrosinemia type 1, 2016-07-27

• Characteristics of exceptional responders to autologous stem cell transplantation in multiple myeloma, 2020-08-28

• Optimizing patient derived mesenchymal stem cells as virus carriers for a Phase I clinical trial in ovarian cancer, 2013-01-24

• Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia, 2017-05-26

• Development of a Clinically Relevant Reporter for Chimeric Antigen Receptor T-Cell Expansion, Trafficking, and Toxicity, 2021-07-08

• Probing Morbillivirus Antisera Neutralization Using Functional Chimerism between Measles Virus and Canine Distemper Virus Envelope Glycoproteins, 2019-07-27

• Antibody neutralization of retargeted measles viruses, 2014-03-14

• Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: Results from a phase 2 trial, 2011-05-31

• TUMOR AND VASCULAR TARGETING OF A NOVEL ONCOLYTIC MEASLES VIRUS RETARGETED AGAINST THE UROKINASE RECEPTOR, 2009-02-10

• Noninvasive 3D imaging of liver regeneration in a mouse model of hereditary tyrosinemia type 1 using the sodium iodide symporter gene, 2015-03-12

• Safety, pharmacokinetics, metabolism and radiation dosimetry of18F-tetrafluoroborate (18F-TFB) in healthy human subjects, 2017-10-27

• The Prognostic Significance of Polyclonal Bone Marrow Plasma Cells in Patients with Relapsing Multiple Myeloma, 2017-07-19

• Advances in oncolytic virotherapy, 2022-04-07

• High scFv-receptor affinity does not enhance the antitumor activity of HER2 retargeted measles virus, 2014-05-30

• Quantitative Molecular Imaging of Viral Therapy for Pancreatic Cancer Using an Engineered Measles Virus Expressing the Sodium-Iodide Symporter Reporter Gene, 2009-04-23

• Oncolytic Viruses as Antigen Agnostic Tumor Vaccines, 2018-04-09

• PRECLINICAL SAFETY AND ACTIVITY OF RECOMBINANT VSV-IFN-B IN AN IMMUNOCOMPETENT MODEL OF SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK, 2014-02-01

• Oncolytic measles virus therapy enhances tumor antigen-specific T-cell responses in patients with multiple myeloma, 2020-04-23

• Discordance between serum cardiac biomarker and immunoglobulin-free light-chain response in patients with immunoglobulin light-chain amyloidosis treated with immune modulatory drugs, 2013-04-11

• Outcomes of primary refractory multiple myeloma and the impact of novel therapies, 2015-10-06

• Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine, 2012-11-07

• Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer, 2010-01-26

• Evaluation of the stability and intratumoral delivery of foreign transgenes encoded by an oncolytic Foamy Virus vector, 2022-02-10

• Revised diagnostic criteria for plasma cell leukemia: results of a Mayo Clinic study with comparison of outcomes to multiple myeloma, 2018-11-15

• Tumor-associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myeloma, 2009-12-23

• IMMUNO-COV v2.0: Development and Validation of a High-Throughput Clinical Assay for Measuring SARS-CoV-2-Neutralizing Antibody Titers, 2021-06-02

• Inter-species variation in monovalent anion substrate selectivity and inhibitor sensitivity in the sodium iodide symporter (NIS), 2020-02-21

• Long-term outcomes of IMiD-based trials in patients with immunoglobulin light-chain amyloidosis: a pooled analysis, 2020-01-08

• Hemagglutinin-specific neutralization of subacute sclerosing panencephalitis viruses, 2018-02-21

• Monitoring the initial delivery of an oncolytic measles virus encoding the human sodium iodide symporter to solid tumors using contrast-enhanced computed tomography, 2014-02-13

• Prognostic Significance of Circulating Plasma Cells by Multi-Parametric Flow Cytometry in Light Chain Amyloidosis, 2018-02-21

• In vivo lentiviral vector gene therapy to cure hereditary tyrosinemia type 1 and prevent development of precancerous and cancerous lesions, 2022-08-25

• Oral contrast enhances the resolution of in-life NIS reporter gene imaging, 2013-09-13

• Oncolytic Measles Virotherapy Does Not Legitimize Opposition To Measles Vaccination, 2019-06-22

• Pinhole Micro-SPECT/CT for Noninvasive Monitoring and Quantitation of Oncolytic Virus Dispersion and Percent Infection in Solid Tumors, 2011-07-14

• Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria, 2018-06-12

• Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects, 2017-05-02

• Cap-dependent translational control of oncolytic measles virus infection in malignant mesothelioma, 2017-06-27

• Mapping of Ion and Substrate Binding Sites in Human Sodium Iodide Symporter (hNIS), 2020-03-12

• Polyinosinic acid decreases sequestration and improves systemic therapy of measles virus, 2011-11-25

• The long-lasting enigma of polycytidine (polyC) tract, 2021-08-04

• A Promising Approach for Treatment of Tumor-Induced Bone Diseases: Utilizing Bisphosphonate Derivatives of Nucleoside Antimetabolites*, 2010-03-15

• New transgenic NIS reporter rats for longitudinal tracking of fibrogenesis by high-resolution imaging, 2018-09-21

• Oncolytic Measles Virus Expressing the Sodium Iodide Symporter to Treat Drug-Resistant Ovarian Cancer, 2014-11-14

• Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients, 2013-10-25

• Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and "Reopening”, 2021-04-28

• Systemically delivered measles virus-infected mesenchymal stem cells can evade host immunity to inhibit liver cancer growth, 2013-07-16

• Reporter gene imaging identifies intratumoral infection voids as a critical barrier to systemic oncolytic virus efficacy, 2014-12-10

• Gene Transfer of Mutant Mouse Cholinesterase Provides High Lifetime Expression and Reduced Cocaine Responses with No Evident Toxicity, 2013-06-28

• Dexamethasone and the risk for adrenal suppression in multiple myeloma, 2009-01-08

• Prostate-Specific Membrane Antigen Retargeted Measles Virotherapy for the Treatment of Prostate Cancer, 2009-07-01

• Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model, 2009-11-24

• Impact of Prior Diagnosis of Monoclonal Gammopathy on Outcomes in Newly Diagnosed Multiple Myeloma, 2019-02-20

• Clinical characteristics and outcomes in Biclonal Gammopathies, 2016-04-06

• A novel report of cIg-FISH and cytogenetics in POEMS syndrome, 2014-03-07

• Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcome, 2018-12-11

• Mathematical Model for Radial Expansion and Conflation of Intratumoral Infectious Centers Predicts Curative Oncolytic Virotherapy Parameters, 2013-09-11

• The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia, 2016-12-20

• ONCOLYTIC VIROTHERAPY, 2012-07-10

• In Vivo Safety, Biodistribution and Antitumor Effects of uPAR Retargeted Oncolytic Measles Virus in Syngeneic Cancer Models, 2014-01-16

• Oncolytic Foamy Virus: Generation and Properties of a Nonpathogenic Replicating Retroviral Vector System That Targets Chronically Proliferating Cancer Cells, 2021-04-26

• Epitope Dampening Monotypic Measles Virus Hemagglutinin Glycoprotein Results in Resistance to Cocktail of Monoclonal Antibodies, 2013-01-03

• Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement, 2018-07-09

• Engineered Measles Virus as a Novel Oncolytic Therapy Against Prostate Cancer, 2009-01-01

• Enhanced noninvasive imaging of oncology models using the NIS reporter gene and bioluminescence imaging, 2019-01-24

• Measles virus for cancer therapy, 2014-02-08